Gene: COL4A1
Official Full Name: collagen type IV alpha 1 chainprovided by HGNC
Gene Summary: This gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO10419 | COL4A1 Knockout cell line (HeLa) | Human | COL4A1 | 1:3~1:6 | Negative | Online Inquiry |
KO10420 | COL4A1 Knockout cell line (HEK293) | Human | COL4A1 | 1:3~1:6 | Negative | Online Inquiry |
KO10421 | COL4A1 Knockout cell line (A549) | Human | COL4A1 | 1:3~1:4 | Negative | Online Inquiry |
COL4A1 Gene Knockout Cell Lines are expertly engineered cellular models that lack functional expression of the COL4A1 gene, which encodes for a critical component of type IV collagen, an essential protein found in basement membranes. These cell lines serve as vital tools for studying the biological implications of COL4A1 deficiency, particularly in the contexts of various diseases, including vascular smooth muscle conditions, cerebrovascular disorders, and ocular diseases.
The primary function of COL4A1 gene knockout cell lines is to enable researchers to elucidate the role of type IV collagen in cellular processes such as adhesion, migration, and differentiation. By utilizing gene editing techniques such as CRISPR-Cas9, these cell lines allow for precise genetic modifications that can mimic pathological states. This facilitates detailed investigations into mechanisms of action at both the molecular and cellular level, providing insights essential for understanding disease progression and potential therapeutic targets.
Scientifically, these knockout cell lines are invaluable in both research and clinical settings. They support robust experimental designs aimed at exploring the consequences of collagen deficiencies—offering hopeful prospects for targeted therapies. Their utilization can lead to breakthroughs in understanding genetic disorders associated with COL4A1 mutations, paving the way for improved diagnostics and treatments.
A standout feature of our COL4A1 Gene Knockout Cell Lines is their specificity and reproducibility, ensuring that experimental results are reliable and can be consistently replicated. Compared to alternative models, which may not fully recapitulate the deficiencies seen in vivo, these cell lines provide a more authentic biological environment for experimental exploration, enhancing the relevance of the findings.
For researchers and clinicians, investing in COL4A1 Gene Knockout Cell Lines is not just about obtaining a product, but also about augmenting their research capabilities with a tool that aligns with cutting-edge methodologies in genetic study. Our company derives from years of expertise in cellular engineering and molecular biology, ensuring that our products are of the highest quality, rigorously tested, and designed with the end-user in mind to advance the forefront of biomedical research and therapeutics.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.